Wolverine Venture Fund invests in Direct Flow Medical

The University of Michigan's student-run VC fund ventured all the way out to California to make its latest investment.

Excerpt:

The University of Michigan's Wolverine Venture Fund has struck again, this time making an investment in a California-based company.

The VC fund, run by MBA students at the University of Michigan, has invested in Direct Flow Medical, an emerging medical device company developing a catheter-based, percutaneous-delivered prosthetic aortic valve. This investment is part of Direct Flow Medical's Series C financing, which has raised $40 million from the likes of EDF Ventures, New Leaf Venture Partners, and Spray Venture Partners.

Read the rest of the story here.
Enjoy this story? Sign up for free solutions-based reporting in your inbox each week.